Toward the development of drug carriers that are capable of crossing biological membranes, controlled emulsion polymerisation has been utilised to produce nanoparticulate carriers from the combination of poly(alkyl cyanoacrylate) and alkylglyceryl dextran to a molecular structure designed to combine the non-immunogenic and stabilising properties of dextran with the demonstrated permeation enhancing ability of alkylglycerols. To this aim, a systematic series of alkylglyceryl dextrans have been synthesised and functionalised with ethyl or butyl cyanoacrylates to form stable polymeric nanocarriers (100-500 nm). Results of investigations into their capability to act as controlled-release devices and their cytotoxicity against bEnd3 cells are reported.
Introduction
One of the major inhibiting factors to the efficient treatment of brain disorders is the lack of universally applicable methods for transporting therapeutic agents across the blood-brain barrier (BBB) [1] [2] [3] [4] . Therapeutic approaches to circumvent the BBB without altering its integrity represent an area of intense activity in drug research, and several methods have been proposed as potential means of improving the access of neuroactives to the brain [5] . Among these methods, the intravascular route is generally regarded as least invasive [4, 6] . Variants of the approach include the: employment of biologically active agents (e.g. mannitol, histamine, nitric oxide, bradykinin, 5-hydroxytryptamine, or cytokines) [7, 8] ; chemical modification or formulation of drugs such that they mimic substrates of influx transporters [9] ; and, the employment of nano-sized carriers [ 10, 11] , liposomes [12, 13] and micro-or nano-sized drug transporters [14, 15] .
Since colloidal carriers, particularly biodegradable polymeric nanoparticles, are often amenable to structural modifications that may bestow to them the capability to enhance drug permeation through the BBB, many researchers regard these structures as promising vehicles for the delivery of drugs to the brain [16, 17] .
Consequent to their proven biocompatibility (following extensive use as medical adhesives [18] ), alkyl cyanoacrylates have long been identified as candidate materials for the fabrication of nanoparticulate vehicles for biomedical applications, especially for the transport of therapeutic agents across the BBB [19, 20] . It has been shown that the coating of such nanoparticles with polysorbate 80 improves stability and enhances the prospect for the therapeutically useful delivery of actives to the brain [19, 21] . While a note of caution has been sounded regarding the use of poly(butylcyanoacrylate) (PBCA; which has been shown by in vitro experiments to exhibit a time and concentration dependent toxicological effect [22, 23] that is linked to the products of its degradation [24] ), the clinical-trial-data based toxicological evaluation of poly(isohexylcyanoacrylate) (PIHCA) did not unmask any adverse effects of therapeutic significance [25] . Although there are not any clinical trials data available for poly(ethylcyanoacrylate) (PECA), the ready availability of its precursor monomer, ECA, renders this polymer a candidate material for the fabrication of nanoparticulate vehicles for biomedical applications.
Since the stability of injectable nanoparticulate formulations can be improved by coating with surfactants, such as poly(ethylene glycol)s, or with non-toxic and non-immunogenic polysaccharides, such as dextran [26] [27] [28] [29] , and considering that alkylglycerols are known to encourage a transient increase in the transport of actives into the brain (when co-administered carotidally with antineoplastics or antibiotics [30] [31] [32] [33] ), alkylglyceryl-modified dextrans are among the materials investigated for their potential to enhance drug penetration across the BBB [34] .
Rationalised by the assumption that a nanoparticulate drug-carrier system based on poly(ethyl cyanoacrylate) and dextran that had been modified with alkylglyceryl moieties may lead to improved particle stability and facilitate increased drug availability to the brain, we report on methods for the preparation of such a system and on the associated physicochemical characterisation and toxicity assessment against mouse brain capillary endothelial cells (bEnd3). TG and DSC analyses (10 K/min heating rate; N2) were performed on TG 209 F1 Libra and DSC 214 ASC Polyma instruments (Netzsch, Germany).
Statistical analysis was performed using SPSS version 22 software; significance was tested using one-way analysis of variance (ANOVA) followed by Scheffe posthoc test (p values were set at level 0.05, unless stated otherwise). Data are presented as mean ± standard deviation. 
Synthesis of alkylglyceryl modified-dextrans (

Preparation of alkylglyceryl dextran-poly(ethyl 2-cyanoacrylate) nanoparticles by controlled
emulsion polymerisation. Ethyl 2-cyanoacrylate (ECA) (600 µL) was added dropwise to alkylglyceryl-dextran (100 mg) in deionised water (100 mL; pH 2.5, HCl) and the mixture was stirred at room temperature for 4 h. After this time the solution was neutralised with NaOH solution (1 N), centrifuged for 15 min (3000 rpm; 1502 g; Rotofix) and further ultracentrifuged for 30 min (12,200 rpm; 18000 g; Beckman ultracentrifuge). The pellet was rinsed with deionized water (10 mL; 3×), then dispersed again in water (10 mL; 10 min sonication) followed by freeze drying.
Preparation of alkylglyceryl dextran-poly(ethyl 2-cyanoacrylate) nanoparticles by emulsion
polymerisation in a water-acetone mix. A solution of ECA (150 µl) in acetone (50 mL) was added gradually under stirring to alkyl glyceryl dextran (250 mg) in deionised water (50 mL).
Stirring was continued overnight at room temperature, after which time the mixture was centrifuged (40,000 rpm, 193,011 g; 30 min), the resulting nanoparticles were rinsed with water (followed by centrifugation) and re-suspended in deionised water (10 mL) prior to freeze drying.
Nanoparticles characterisation. The resulting nanoparticulate white powders were characterised by 1 H-NMR spectroscopy as well as elemental and thermogravimetric analysis.
Dispersions of these nanoparticles (concentration range 10 -100 µg/mL) were prepared by vortex and sonication in deionized water or PBS.
A Malvern Zetasizer Nano ZS instrument equipped with a 633 nm He-Ne laser (173° backscattering angle detection) and controlled by Zetasizer v7.01 software was used to determine the hydrodynamic diameter of nanoparticles; samples were analysed in triplicate using For release studies, the centrifuged pellet was dispersed in deionised water (10 mL) by sonication (10 min) and an aliquot (5 mL) of each sample (either PECA-Dex6G4-Dox or PECA-Dex6G8-Dox) was placed in a dialysis membrane bag that had been immersed in Falcon tubes containing PBS (20 mL). The tubes were incubated in an oscillating water bath (37 °C; 100 rpm) and, at specified time intervals, an aliquot (1 mL) was withdrawn and replaced with fresh media. Fluorescence intensity was measured in the supernatant and the amount of drug released at each time point was quantified by means of a calibration curve.
The calculated amount of the equivalent content of free Doxorubicin hydrochloride in nanoparticles was used as control. To evaluate the retentive capacity of nanoparticles, the colloidal mixture formed after loading Evans Blue to PECA-Dex6G4 nanoparticles was centrifuged twice and, after each centrifugation cycle, the absorbance of the supernatant was measured. The degree of loading after the second centrifugation was determined as 0.016 % and the efficiency of entrapment was 2.034 %. Similar results were obtained for the entrapment of Evans blue into PECADex6G12 nanoparticles. Generally, nanoparticles loaded with Evans blue via the monomer polymerisation method exhibited poor entrapment efficiency and a correspondingly low degree of loading; since Evans blue is a negatively charged dye, it is likely that the negative zeta potential of PECA-alkyl glyceryl dextran nanoparticles is accountable for the poor compatibility displayed by this dye-nanoparticle system.
Fluorescent labelling
The fluorescent tagging of nanoparticles with MIA was performed by adapting a previously 
Results and discussion
Dextrans of different molecular weight (6 and 100 kDa) were grafted with alkylglyceryl chains (butyl, octyl, dodecyl, tetradecyl, or hexadecyl) via nucleophilic substitution using alkyloxy-substituted oxiranes in the presence of potassium t-butoxide. The degree of substitution (DS%, expressed as the number of alkylglyceryl chains per 100 glucopyranose units of dextran) was calculated from the 1 H-NMR spectra using Equation 1:
where C4' is the integral of the signal assigned to the alkyl chain CH3 end group (0.86 ppm), and C1 is the integral of the signal assigned to the anomeric proton (4.67 ppm).
The degree of substitution, which varied widely (from 50 to 150 %, Table 1 ), was found to increase with reaction time and with the excess of oxirane employed. Since the reactivity of the OH group of dextran towards alkylating agents is known to decrease in the order C2 > C4 No notable chain-length or molecular-weight dependent variations in the degree of substitution of the commercial dextrans employed were observed in this study.
The FTIR spectra of native dextran is characterised by skeletal vibrational modes (δC-C-C, Pullulan standards allowed the determination by GPC of the molecular weight distribution profile of the synthesised alkylglyceryl dextrans and that of the starting material. Owing to differences in the experimental protocol, the average molecular weights of commercial dextrans that served as starting materials (Dex 6 kDa and Dex 100 kDa) were higher than those claimed by the manufacturer. In accord with expectation, a study involving Dex100
showed that the synthesised Dex100G16 (DS 144.92 %) had a higher average molecular weight (188.309 kDa) than its precursor macromolecule Dex100 (109.399 kDa). Indicative of the comparative nature of the technique, GPC-determined values did not match those calculated from NMR data (366.62 kDa for Dex100G16). Similarly, the GPC-determined average molecular weight of Dex6G4 (DS 87.7 %) was lower (5.469 kDa) than that calculated from NMR data (10.228 kDa) and, interestingly, lower than that measured by GPC for its precursor dextran (Dex6; 9.811 kDa). Irrespective of molecular weight, the PDI values of synthesised alkyl glyceryl dextrans (e.g. 1.0 for Dex100G16 and 1.5 for Dex6G4) were lower than those of precursor dextrans (e.g. 4.4 for Dex100 and 2.3 for Dex6), which is consistent with the assumption that the purification process that follows the grafting of alkylglyceryl chains to dextrans reduces the polydispersity of materials. Table 1 .
Thermogravimetric analysis of alkylglyceryl dextrans revealed two discrete mass loss events ( Figure 2A ,B and Table 1 Figure 2C) ; for Dex6-and Dex100-based materials, the water content was found to decrease with increasing alkyl-chain length (the longer the alkyl chain length, the less hydrophilic the sample and the lower its water content). This was however not reflected in the behaviour of Dex6G8, Figure 2C , due to its higher degree of functionalization (115 %, compared to 65 % for Dex100G8; Table 1 ).
Irrespective of molecular weight, the residual mass of alkyl glyceryl dextrans was found to be lower than that of the corresponding unmodified dextrans, and did not appear to correlate with the alkyl chain length (Table 1 ). 
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DSC data did not provide any evidence for the presence of crystallinity in any of the samples under study. Interestingly, two glass transition events were identified in samples of the unmodified dextran ( Figure 2D ) and also in those of short-chained alkylglyceryl dextrans.
Dextrans substituted with long alkyl chains (octyl or longer) did not exhibit the higher temperature glass transition ( Table 2 ). In accord with TG data, the total enthalpy change characterising the evaporation of residual water (seen as a large endotherm in the first DSC run, e.g. Figure 2D ; summarized in Table 2 ) decreases with increasing alkyl chain length. The temperature values for the first glass transition (expressed as median points) were slightly higher for materials based on the high molecular weight dextrans (Dex100) than for those based on Dex6.
In situ anionic emulsion polymerisation of ethyl cyanoacrylate in the presence of alkylglyceryl dextrans resulted in the formation of alkylglyceryl-dextran-poly(ethyl cyanoacrylate) nanoparticles. To effect control over the rate of polymerization, reactions were carried out under acidic conditions (pH 2.5) [19, 22, 46] . Following purification and drying, nanoparticles were isolated as white powders that were characterized by NMR and elemental analysis. Nanoparticles were also formulated without HCl, in a water-acetone mix (Table 3 , samples 6 and 10), but this appears to be of little influence on the elemental composition (i.e. on the ratio of PECA to alkylglyceryl dextran found in the nanoparticles). (Table 3) . Consistent with findings regarding the ratio of dextran to alkyl cyanoacrylate, the elemental-analysis-determined percentage composition (w/w) of dextran and poly (isobutyl cyanoacrylate), PIBCA, is reported at 22 % and 78 %, respectively [26] .
Since sequential washing and centrifugation of nanoparticles from dextran and BCA is known to gradually increase the PBCA:dextran ratio (up to ca. 9:1), it may be reasonably assumed that a proportion of the dextran component is associated with the nanoparticles via physisorption [47]. Table 3 .
Mass spectroscopy investigations by MALDI-TOF revealed a spectral pattern with characteristic peak-to-peak mass differences of 130.2 and 146.2, likely due to fragmentation at the O-C bond level ( Figure 4A ). This is indicative of a fragmentation pathway that is To evaluate the stability of PECA and PECA-alkylglyceryl nanoparticles as a function of pH, the size and zeta potential of nanoparticles re-dispersed in ultrapure water (example in Figure   6 ) were monitored during automatic pH titrations with aq. HCl (0.005/0.05M). Results
showed that, for all formulations, the average particle sizes at pH 7.4 were in the range 100-500 nm and the zeta potential between -15 and -30 mV. It was found that the zeta potential of PECA nanoparticles and PECA-alkylglyceryl dextran nanoparticles increased with decreasing pH, with isoelectric points at low pH values (< 3.2). Although pH-induced changes in the size of nanoparticles were observable, the average nanoparticle size was relatively stable over the pH range 3-8; PECA-Dex6G16 nanoparticles were least amenable to pH-induced variations in size ( Figure 6 ).
To (Table 4 ; also Supplementary material). nanospheres exert a low cytotoxic effect on A549 cells (viability >92 %) [20] and there was no noticeable induced cytotoxicity at the concentration of 75µg/mL [24] , membrane damage has been observed at 150 µg/ml [24] . Notably, while reports from clinical trials indicate that PACA degradation products do not induce any adverse effects of therapeutic significance [25] , no clinical trials that are specific to either PECA or PBCA have been conducted. 
Supplementary information S-1. Biodegradation studies
S-2. MTT assay MTT (3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide) assay protocol
The MTT working solution was prepared by allowing a solution of MTT in DMEM (5 mg/mL; kept in the dark at 2-8°C until needed) to reach 37°C and a steady state concentration of 5% CO2 before dilution (1:5) with DMEM. BEnd3 cells (20,000) were seeded (in triplicate) into each of a 96 well plate containing 200 µl of normal media (DMEM containing 10% fetal bovine serum, FBS) and incubated for 24h. After this time, in each well were added 20 µl of each nanoformulation and of alkylglyceryl dextran formulations dispersed in PBS at specified concentrations prior to incubation for 24h at 37°C (5% CO2). After this time, to each well was added MTT working solution (50 µl) and the mixture was incubated for 2h at 37°C (5% CO2). The media was then removed from each well, replaced with 100 µl of DMSO and this mixture was agitated gently until the formazan crystals had dissolved.
Each plate was inserted into the plate reader and the absorbance was read at 570 nm. The 
